Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-blind, Placebo- and Active-controlled Evaluation of the Safety and Efficacy of Levomilnacipran ER in Pediatric Patients 7-17 Years With Major Depressive Disorder

NCT03569475 is registered in ClinicalTrials.gov with Allergan as lead sponsor.

NCT NCT03569475
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03569475 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-blind, Placebo- and Active-controlled Evaluation of the Safety and Efficacy of Levomilnacipran ER in Pediatric Patients 7-17 Years With Major Depressive Disorder
Lead sponsor
Allergan
Phase
Phase 3
Overall status
Completed
Start date
July 6, 2018
Completion date
March 1, 2021
Enrollment
501 (actual)
Sites
51

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive disorder